Candela Martin

Gedeon Richter España

Based in Hungary, Gedeon Richter Plc. is a leading European pharmaceutical and biotechnology multinational in Women's Health Care. Founded in 1901 by Hungarian pharmacist Gedeon Richter, the company has now grown into a multinational pharmaceutical company with a presence in more than 100 countries. The company has more than 12.000 employees worldwide and is headquartered in Budapest. Currently, the company's positioning is based on a firm commitment to the therapeutic areas of Gynecology, Fertility, the Central Nervous System and Cardiovascular, as well as manufacturing in biotechnology and innovation and R&D, developing drugs that meet the needs women's health at all stages of their lives. Innovation and research into original pharmacological molecules have always been a fundamental element of the company's strategy. Gedeon Richter's research and development area has more than 1.200 employees, and its priority areas of interest are the treatment of benign gynecological pathologies and CNS diseases. The company manufactures more than 200 medicines including originator, generic and licensed drugs that provide treatments for most therapeutic areas. Headquartered in Barcelona, since 2011 the subsidiary has focused on marketing innovative therapeutic solutions in Gynecology. In 2017, a new Fertility business unit was added, thanks to the acquisition of the Swiss biotechnology company Finox Holding. In 2019, Gedeon Richter enters into the bone metabolism market.